EnteroBiotix partners with Imperial College London to develop microbiome therapeutics ...Middle East

PR Newswire - News
Partnership includes a Phase II clinical trial using microbiome therapeutics funded by the Medical Research Council (MRC) aiming to potentiate allo-HCT in patients suffering from haematological malignancy Combines expertise at Imperial with EnteroBiotix's AMPLA™ platform and Medicines and...

Hence then, the article about enterobiotix partners with imperial college london to develop microbiome therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EnteroBiotix partners with Imperial College London to develop microbiome therapeutics )

Apple Storegoogle play

Last updated :

Also on site :